Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.
about
Prostasin induces protease-dependent and independent molecular changes in the human prostate carcinoma cell line PC-3Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factorMP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancerMatriptase is involved in ErbB-2-induced prostate cancer cell invasionThe epidermal growth factor receptor (EGFR) is proteolytically modified by the Matriptase-Prostasin serine protease cascade in cultured epithelial cells.A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancer.EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/AktSignaling mechanisms coupled to CXCL12/CXCR4-mediated cellular proliferation are PTEN-dependent.Human pancreatic secretory trypsin inhibitor stabilizes intestinal mucosa against noxious agents.A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer.Human prostatic acid phosphatase: structure, function and regulation.Prediction of functional phosphorylation sites by incorporating evolutionary informationTargeting prostate cancer based on signal transduction and cell cycle pathways.The ERBB3 receptor in cancer and cancer gene therapyA novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer.Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway.Antitumor effects of carnertinib in castration resistant prostate cancer models: a comparative study with erlotinib.Hyaluronan suppresses prostate tumor cell proliferation through diminished expression of N-cadherin and aberrant growth factor receptor signaling.Differential efficacy of combined therapy with radiation and AEE788 in high and low EGFR-expressing androgen-independent prostate tumor models.Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profiling.Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17.Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications.Simulating non-small cell lung cancer with a multiscale agent-based model.Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway.SRPK1 contributes to malignancy of hepatocellular carcinoma through a possible mechanism involving PI3K/Akt.Differential array sensing for cancer cell classification and novelty detection.Role of Stromal Paracrine Signals in Proliferative Diseases of the Aging Human Prostate.
P2860
Q24677062-0FA5FC9F-B54D-43AE-9B51-E28AF8960FD4Q28115391-AF1C3B96-0401-4D21-B12A-49306396E55AQ33443571-D3E64D2B-F610-4ED5-BDCF-1995BCA3EDC2Q34358331-64D348AA-CC70-4C06-9F3B-AF776A6B5B70Q35546542-4FAE3E86-14FC-43DB-AE5A-3ABF6EF67496Q35678429-7EAFFF55-0F32-4444-8AF7-82BE56895383Q35945055-F9DFE70A-A876-40B5-A140-8003A1209CE6Q35962850-6489A1A0-4C2E-4570-BEA3-B913A2B3EF24Q36095586-9D9346BA-D1E4-4880-82B0-7A4B8FD35D20Q36462972-CC1B715B-07A5-4A4C-9BE0-4AE3A0054FCBQ36913762-D010A17F-2CAE-4893-8FFA-EB2F36C3A2E4Q36922913-AF20FC4B-9434-473E-87CE-CA587882D8ECQ36995054-2A18E990-2E54-4108-8C65-7DAAEC2A4E9DQ37135372-296A5BBB-863F-498F-9E8D-9080088EDF79Q37599474-053CF02B-2C91-4BBA-9029-7C9D1DD541C8Q38964675-6028D81F-D548-4F5E-861D-C378B80E8197Q39033598-FB286999-51D8-4FFA-B5BB-6AE577C3C6BFQ39372010-407115C9-86BB-4B80-A29D-25A779A6D68AQ39568883-04F2FF02-8CD4-4922-B189-18CE83BC5EFEQ39593897-90DBBBE7-7326-435B-A21E-2710DC1A632CQ39635478-C02759E8-B46D-417C-8108-5A6429B97503Q39871570-14EF6943-692B-4E57-927E-C306824364BDQ40066641-67FFA247-C3E1-40DD-88F6-C84EC9D8BBF0Q42108610-999CA78B-02B9-4112-86DF-36918C99F64CQ42861436-55E27961-BE4B-4CD9-80D9-AA81A85EE193Q43060191-9609EC3A-3254-40C7-97C4-D4097E88997FQ44206065-95E5C6CB-E1A6-4918-A237-E0F1BF5A03DAQ47594191-A1563C57-89C9-4F3D-9C60-352BBB8397A0Q52721968-12729E4A-25CE-4093-B09A-D133A620F560
P2860
Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Phosphorylation of both EGFR a ...... liferation in response to EGF.
@en
type
label
Phosphorylation of both EGFR a ...... liferation in response to EGF.
@en
prefLabel
Phosphorylation of both EGFR a ...... liferation in response to EGF.
@en
P2093
P2860
P356
P1433
P1476
Phosphorylation of both EGFR a ...... oliferation in response to EGF
@en
P2093
Gordon Stamp
Soha Salama El Sheikh
P2860
P304
P356
10.1593/NEO.04379
P577
2004-11-01T00:00:00Z